Exagen, Inc. (XGN)
8.42
+0.25
(+3.06%)
USD |
NASDAQ |
Oct 09, 16:00
8.42
0.00 (0.00%)
After-Hours: 20:00
Exagen Free Cash Flow (Quarterly) : 3.445M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.445M |
| March 31, 2026 | -10.64M |
| December 31, 2025 | -3.057M |
| September 30, 2025 | 2.669M |
| June 30, 2025 | -3.094M |
| March 31, 2025 | -10.78M |
| December 31, 2024 | 0.217M |
| September 30, 2024 | -2.323M |
| June 30, 2024 | -2.562M |
| March 31, 2024 | -9.126M |
| December 31, 2023 | 8.243M |
| September 30, 2023 | -2.91M |
| June 30, 2023 | -10.48M |
| March 31, 2023 | -10.14M |
| December 31, 2022 | -6.14M |
| September 30, 2022 | -7.561M |
| June 30, 2022 | -13.10M |
| March 31, 2022 | -9.661M |
| December 31, 2021 | -7.111M |
| September 30, 2021 | -5.935M |
| June 30, 2021 | -5.164M |
| March 31, 2021 | -4.479M |
| December 31, 2020 | -3.904M |
| Date | Value |
|---|---|
| September 30, 2020 | -2.341M |
| June 30, 2020 | -4.909M |
| March 31, 2020 | -3.385M |
| December 31, 2019 | -3.953M |
| September 30, 2019 | -1.668M |
| June 30, 2019 | -2.18M |
| March 31, 2019 | -2.313M |
| December 31, 2018 | -1.94M |
| September 30, 2018 | -2.084M |
| June 30, 2018 | -1.994M |
| March 31, 2018 | -3.482M |
| December 31, 2015 | -3.543M |
| September 30, 2015 | -3.142M |
| June 30, 2015 | -3.238M |
| March 31, 2015 | -2.784M |
| December 31, 2014 | -2.486M |
| September 30, 2014 | -2.567M |
| June 30, 2014 | -3.127M |
| March 31, 2014 | -3.242M |
| December 31, 2013 | -2.389M |
| September 30, 2013 | -1.453M |
| June 30, 2013 | -1.391M |
| March 31, 2013 | -1.804M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Myriad Genetics, Inc. | -11.50M |
| BioRestorative Therapies, Inc. | -3.808M |
| CareDx, Inc. | 28.75M |
| Natera, Inc. | -8.636M |
| Sera Prognostics, Inc. | -6.363M |